Cost-effectiveness of sequential treatment with abaloparatide followed by alendronate vs. alendronate monotherapy in women at increased risk of fracture: A US payer perspective.
Semin Arthritis Rheum
; 50(3): 394-400, 2020 06.
Article
in En
| MEDLINE
| ID: mdl-32160943
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Alendronate
/
Parathyroid Hormone-Related Protein
/
Bone Density Conservation Agents
/
Osteoporotic Fractures
Type of study:
Etiology_studies
/
Guideline
/
Health_economic_evaluation
/
Prognostic_studies
/
Risk_factors_studies
Aspects:
Patient_preference
Limits:
Aged
/
Aged80
/
Female
/
Humans
/
Middle aged
Language:
En
Journal:
Semin Arthritis Rheum
Year:
2020
Document type:
Article
Country of publication:
Estados Unidos